Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NEUMORA-THERAPEUTICS-INC-159308146/news/Neumora-Therapeutics-Announces-Clinical-Hold-of-Phase-1-NMRA-266-Study-46437773/?utm_source=whatsapp&utm_medium=social&utm_campaign=share